NRG1 concentration < 1021 pg/ml showed 97% sensitivity and 9% specificity for screening MS versus healthy controls, while < 226.6 pg/ml yielded high specificity (95%) but low sensitivity (19%) for diagnosis. Here, NRG1 is linked to myeloid sarcoma.